Raymond James & Associates’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-20,659
| Closed | -$200K | – | 3828 |
|
|
2022
Q3 | $200K | Sell |
20,659
-7,228
| -26% | -$70K | ﹤0.01% | 3419 |
|
|
2022
Q2 | $404K | Sell |
27,887
-1,283
| -4% | -$18.6K | ﹤0.01% | 3028 |
|
|
2022
Q1 | $762K | Sell |
29,170
-70,469
| -71% | -$1.84M | ﹤0.01% | 2770 |
|
|
2021
Q4 | $3.95M | Sell |
99,639
-19,363
| -16% | -$767K | ﹤0.01% | 1703 |
|
|
2021
Q3 | $5.95M | Buy |
119,002
+8,387
| +8% | +$419K | 0.01% | 1386 |
|
|
2021
Q2 | $6.14M | Buy |
110,615
+4,173
| +4% | +$232K | 0.01% | 1353 |
|
|
2021
Q1 | $4.98M | Buy |
106,442
+9,395
| +10% | +$439K | 0.01% | 1427 |
|
|
2020
Q4 | $4.22M | Sell |
97,047
-1,190
| -1% | -$51.8K | ﹤0.01% | 1435 |
|
|
2020
Q3 | $3.6M | Buy |
98,237
+32,987
| +51% | +$1.21M | ﹤0.01% | 1402 |
|
|
2020
Q2 | $1.9M | Buy |
65,250
+53,420
| +452% | +$1.56M | ﹤0.01% | 1759 |
|
|
2020
Q1 | $309K | Buy |
+11,830
| New | +$309K | ﹤0.01% | 2733 |
|